Home › Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform
 

Keywords :   


Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform

2015-02-27 01:59:32| drugdiscoveryonline Home Page

Nodality, Inc., which is focused on solving drug development challenges, recently announced research results from its lead immuno-oncology efforts based on applications of the Company’s Single Cell Network Profiling (SCNP) technology

Tags: data program single network

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.12South Western Railway to be renationalised by Labour
03.12Woolchemy Develops Wool-Based ADL Materials
03.12Labelexpo South China 2024 features latest industry trends
03.12PPG Earns Two Awards During CARES 2024 Automotive Forums in U.S., Europe
03.12Filtrex 2025 to be Held in March
03.12Nu-Maber Italy adds dual ThermoFlexX Catena-E 80 units
03.12TEKLYNX assists with label compliance
03.12Megnajet supporting Arrow Systems\' growing digital portfolio
More »